Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Cox

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Pediatric Rehabilitation|June 19, 2004
Physical performance testing in mucopolysaccharidosis I: a pilot studyHelene M Dumas, Maria A Fragala, Stephen M Haley, et al.
The American Journal of Surgical Pathology|May 23, 2012
Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B)Beth L Thurberg, Melissa P Wasserstein, Thomas Schiano, et al.
Molecular Genetics and Metabolism Reports|January 20, 2023
Neuropsychological endpoints for clinical trials in methylmalonic acidemia and propionic acidemia: A pilot studyKimberly A Chapman, Devon MacEachern, Gerald F Cox, et al.
The American Journal of Surgical Pathology|June 25, 2016
Clearance of Hepatic Sphingomyelin by Olipudase Alfa Is Associated With Improvement in Lipid Profiles in Acid Sphingomyelinase DeficiencyBeth L Thurberg, Melissa P Wasserstein, Simon A Jones, et al.
Developmental Medicine and Child Neurology|June 20, 2006
A physical performance measure for individuals with mucopolysaccharidosis type IStephen M Haley, Maria A Fragala Pinkham, Helene M Dumas, et al.
Molecular Genetics and Metabolism|January 15, 2014
Lyso-sphingomyelin is elevated in dried blood spots of Niemann-Pick B patientsWei-Lien Chuang, Joshua Pacheco, Samantha Cooper, et al.
Blood Cells, Molecules & Diseases|January 28, 2017
A pooled analysis of adverse events in 393 adults with Gaucher disease type 1 from four clinical trials of oral eliglustat: Evaluation of frequency, timing, and durationM Judith Peterschmitt, Gerald F Cox, Jennifer Ibrahim, et al.
European Journal of Pediatrics|January 12, 2012
Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I RegistryKristin D'Aco, Lisa Underhill, Lakshmi Rangachari, et al.
American Journal of Medical Genetics. Part A|November 15, 2007
Encephalocraniocutaneous lipomatosis accompanied by the formation of bone cysts: Harboring clues to pathogenesis?Ute Moog, Filip Roelens, Geert R Mortier, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 4, 2015
Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann-Pick disease type B (acid sphingomyelinase deficiency)Margaret M McGovern, Melissa P Wasserstein, Brian Kirmse, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Pediatric Rehabilitation|June 19, 2004
Physical performance testing in mucopolysaccharidosis I: a pilot studyHelene M Dumas, Maria A Fragala, Stephen M Haley, et al.
The American Journal of Surgical Pathology|May 23, 2012
Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B)Beth L Thurberg, Melissa P Wasserstein, Thomas Schiano, et al.
Molecular Genetics and Metabolism Reports|January 20, 2023
Neuropsychological endpoints for clinical trials in methylmalonic acidemia and propionic acidemia: A pilot studyKimberly A Chapman, Devon MacEachern, Gerald F Cox, et al.
The American Journal of Surgical Pathology|June 25, 2016
Clearance of Hepatic Sphingomyelin by Olipudase Alfa Is Associated With Improvement in Lipid Profiles in Acid Sphingomyelinase DeficiencyBeth L Thurberg, Melissa P Wasserstein, Simon A Jones, et al.
Developmental Medicine and Child Neurology|June 20, 2006
A physical performance measure for individuals with mucopolysaccharidosis type IStephen M Haley, Maria A Fragala Pinkham, Helene M Dumas, et al.
Molecular Genetics and Metabolism|January 15, 2014
Lyso-sphingomyelin is elevated in dried blood spots of Niemann-Pick B patientsWei-Lien Chuang, Joshua Pacheco, Samantha Cooper, et al.
Blood Cells, Molecules & Diseases|January 28, 2017
A pooled analysis of adverse events in 393 adults with Gaucher disease type 1 from four clinical trials of oral eliglustat: Evaluation of frequency, timing, and durationM Judith Peterschmitt, Gerald F Cox, Jennifer Ibrahim, et al.
European Journal of Pediatrics|January 12, 2012
Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I RegistryKristin D'Aco, Lisa Underhill, Lakshmi Rangachari, et al.
American Journal of Medical Genetics. Part A|November 15, 2007
Encephalocraniocutaneous lipomatosis accompanied by the formation of bone cysts: Harboring clues to pathogenesis?Ute Moog, Filip Roelens, Geert R Mortier, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 4, 2015
Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann-Pick disease type B (acid sphingomyelinase deficiency)Margaret M McGovern, Melissa P Wasserstein, Brian Kirmse, et al.
Pageof 8